Institutional validation of breast cancer treatment guidelines

Journal of Surgical Research

Volumn 100, Issue 1, 2001, Pages 106-109

  Minter, R M ^a   Spengler, K K ^a   Topping, D P ^a   Flug, R ^a   Copeland III, E M ^a   Lind, D S ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer; Clinical guidelines; NCCN

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; FOLLOW UP; HOSPITAL COST; HUMAN; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; VALIDATION PROCESS;

EID: 0034869815     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2000.5895     Document Type: Article

References (12)

1. General surgical clinical pathways: An introduction
2. Practice guidelines: A new reality in medicine. I. Recent developments
3. Clinical practice guidelines
4. Breast cancer surgical practice guidelines. Society of Surgical Oncology practice guidelines
5. American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelines
6. Update: NCCN practice guidelines for the treatment of breast cancer. National Comprehensive Cancer Network
7. The ASCO experience with evidence-based clinical practice guidelines
8. The National Comprehensive Cancer Network: Present and future directions
9. Compliance with practice guidelines for node-negative breast cancer
10. The quality of care for treatment of early stage breast carcinoma: Is it consistent with national guidelines?
11. Impact of a clinical guidelines program for breast and colon cancer in a French cancer center
12. Consensus statement on postmastectomy radiation therapy